Asymmetrical olfactory acuity and neuroleptic treatment in schizophrenia
Identifieur interne : 004596 ( Istex/Corpus ); précédent : 004595; suivant : 004597Asymmetrical olfactory acuity and neuroleptic treatment in schizophrenia
Auteurs : S. E. Purdon ; P. Flor-HenrySource :
- Schizophrenia Research [ 0920-9964 ] ; 1999.
English descriptors
- KwdEn :
Abstract
Uni-rhinal olfactory acuity in schizophrenia was investigated in two experiments. The first assessed the presence of a predicted atypical asymmetry of nostril laterality and the second assessed the effect of antipsychotic treatment on the asymmetry. Although olfactory identification impairment has been well documented in schizophrenia, olfactory acuity has been neglected. This may be an oversight as cerebral structures of the mesial temporal lobe important to olfactory perception have often been implicated in the pathophysiology of schizophrenia and it is thus reasonable to postulate a primary impairment of olfactory acuity in schizophrenia. In addition, unmedicated patients with schizophrenia have exhibited asymmetrical laterality favouring the right over the left hemisphere in studies of visual, haptic, and auditory perception, and the few published prospective treatment studies have suggested a reversal of this asymmetry with first generation neuroleptic treatments. In experiment 1 a generalization of the perceptual asymmetry to olfactory acuity was examined by measurement of n-butanol olfactory thresholds with the Connecticut Chemosensory Perception Exam (CCPE) in an unmedicated sample of 17 patients with schizophrenia and 17 age, gender, and handedness matched normal controls. The patient sample showed an asymmetrical impairment of the left nostril that was not apparent in the normal control sample. In experiment 2, the CCPE was administered to a new sample of 10 patients with schizophrenia before and after neuroleptic treatment. The asymmetry observed in experiment 1 was replicated, and the relative advantage of the right nostril shifted to a relative advantage of the left nostril over the course of 8weeks of treatment. Results are discussed in relation to cerebral aspects of schizophrenia and potential implications to cognitive change from treatment.
Url:
DOI: 10.1016/S0920-9964(99)00212-1
Links to Exploration step
ISTEX:BB6AABFDC91AA33BC678D96652290E9E4C584961Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title>Asymmetrical olfactory acuity and neuroleptic treatment in schizophrenia</title><author><name sortKey="Purdon, S E" sort="Purdon, S E" uniqKey="Purdon S" first="S. E." last="Purdon">S. E. Purdon</name><affiliation><mods:affiliation>Alberta Hospital Edmonton, Box 307, Edmonton, Alberta, T5J 2J7 Canada</mods:affiliation></affiliation></author><author><name sortKey="Flor Henry, P" sort="Flor Henry, P" uniqKey="Flor Henry P" first="P." last="Flor-Henry">P. Flor-Henry</name><affiliation><mods:affiliation>Alberta Hospital Edmonton, Box 307, Edmonton, Alberta, T5J 2J7 Canada</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: scot.Purdon@AMHB.AB.CA</mods:affiliation></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:BB6AABFDC91AA33BC678D96652290E9E4C584961</idno><date when="2000" year="2000">2000</date><idno type="doi">10.1016/S0920-9964(99)00212-1</idno><idno type="url">https://api.istex.fr/document/BB6AABFDC91AA33BC678D96652290E9E4C584961/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">004596</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a">Asymmetrical olfactory acuity and neuroleptic treatment in schizophrenia</title><author><name sortKey="Purdon, S E" sort="Purdon, S E" uniqKey="Purdon S" first="S. E." last="Purdon">S. E. Purdon</name><affiliation><mods:affiliation>Alberta Hospital Edmonton, Box 307, Edmonton, Alberta, T5J 2J7 Canada</mods:affiliation></affiliation></author><author><name sortKey="Flor Henry, P" sort="Flor Henry, P" uniqKey="Flor Henry P" first="P." last="Flor-Henry">P. Flor-Henry</name><affiliation><mods:affiliation>Alberta Hospital Edmonton, Box 307, Edmonton, Alberta, T5J 2J7 Canada</mods:affiliation></affiliation><affiliation><mods:affiliation>E-mail: scot.Purdon@AMHB.AB.CA</mods:affiliation></affiliation></author></analytic><monogr></monogr><series><title level="j">Schizophrenia Research</title><title level="j" type="abbrev">SCHRES</title><idno type="ISSN">0920-9964</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="1999">1999</date><biblScope unit="volume">44</biblScope><biblScope unit="issue">3</biblScope><biblScope unit="page" from="221">221</biblScope><biblScope unit="page" to="232">232</biblScope></imprint><idno type="ISSN">0920-9964</idno></series><idno type="istex">BB6AABFDC91AA33BC678D96652290E9E4C584961</idno><idno type="DOI">10.1016/S0920-9964(99)00212-1</idno><idno type="PII">S0920-9964(99)00212-1</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0920-9964</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>UPSIT</term><term>acuity</term><term>asymmetry</term><term>laterality</term><term>neuroleptic.</term><term>olfaction</term><term>schizophrenia</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Uni-rhinal olfactory acuity in schizophrenia was investigated in two experiments. The first assessed the presence of a predicted atypical asymmetry of nostril laterality and the second assessed the effect of antipsychotic treatment on the asymmetry. Although olfactory identification impairment has been well documented in schizophrenia, olfactory acuity has been neglected. This may be an oversight as cerebral structures of the mesial temporal lobe important to olfactory perception have often been implicated in the pathophysiology of schizophrenia and it is thus reasonable to postulate a primary impairment of olfactory acuity in schizophrenia. In addition, unmedicated patients with schizophrenia have exhibited asymmetrical laterality favouring the right over the left hemisphere in studies of visual, haptic, and auditory perception, and the few published prospective treatment studies have suggested a reversal of this asymmetry with first generation neuroleptic treatments. In experiment 1 a generalization of the perceptual asymmetry to olfactory acuity was examined by measurement of n-butanol olfactory thresholds with the Connecticut Chemosensory Perception Exam (CCPE) in an unmedicated sample of 17 patients with schizophrenia and 17 age, gender, and handedness matched normal controls. The patient sample showed an asymmetrical impairment of the left nostril that was not apparent in the normal control sample. In experiment 2, the CCPE was administered to a new sample of 10 patients with schizophrenia before and after neuroleptic treatment. The asymmetry observed in experiment 1 was replicated, and the relative advantage of the right nostril shifted to a relative advantage of the left nostril over the course of 8weeks of treatment. Results are discussed in relation to cerebral aspects of schizophrenia and potential implications to cognitive change from treatment.</div></front></TEI><istex><corpusName>elsevier</corpusName><author><json:item><name>S.E. Purdon</name><affiliations><json:string>Alberta Hospital Edmonton, Box 307, Edmonton, Alberta, T5J 2J7 Canada</json:string></affiliations></json:item><json:item><name>P. Flor-Henry</name><affiliations><json:string>Alberta Hospital Edmonton, Box 307, Edmonton, Alberta, T5J 2J7 Canada</json:string><json:string>E-mail: scot.Purdon@AMHB.AB.CA</json:string></affiliations></json:item></author><subject><json:item><lang><json:string>eng</json:string></lang><value>acuity</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>asymmetry</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>laterality</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>neuroleptic.</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>olfaction</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>schizophrenia</value></json:item><json:item><lang><json:string>eng</json:string></lang><value>UPSIT</value></json:item></subject><language><json:string>eng</json:string></language><abstract>Uni-rhinal olfactory acuity in schizophrenia was investigated in two experiments. The first assessed the presence of a predicted atypical asymmetry of nostril laterality and the second assessed the effect of antipsychotic treatment on the asymmetry. Although olfactory identification impairment has been well documented in schizophrenia, olfactory acuity has been neglected. This may be an oversight as cerebral structures of the mesial temporal lobe important to olfactory perception have often been implicated in the pathophysiology of schizophrenia and it is thus reasonable to postulate a primary impairment of olfactory acuity in schizophrenia. In addition, unmedicated patients with schizophrenia have exhibited asymmetrical laterality favouring the right over the left hemisphere in studies of visual, haptic, and auditory perception, and the few published prospective treatment studies have suggested a reversal of this asymmetry with first generation neuroleptic treatments. In experiment 1 a generalization of the perceptual asymmetry to olfactory acuity was examined by measurement of n-butanol olfactory thresholds with the Connecticut Chemosensory Perception Exam (CCPE) in an unmedicated sample of 17 patients with schizophrenia and 17 age, gender, and handedness matched normal controls. The patient sample showed an asymmetrical impairment of the left nostril that was not apparent in the normal control sample. In experiment 2, the CCPE was administered to a new sample of 10 patients with schizophrenia before and after neuroleptic treatment. The asymmetry observed in experiment 1 was replicated, and the relative advantage of the right nostril shifted to a relative advantage of the left nostril over the course of 8weeks of treatment. Results are discussed in relation to cerebral aspects of schizophrenia and potential implications to cognitive change from treatment.</abstract><qualityIndicators><score>8</score><pdfVersion>1.2</pdfVersion><pdfPageSize>546 x 743 pts</pdfPageSize><refBibsNative>true</refBibsNative><keywordCount>7</keywordCount><abstractCharCount>1889</abstractCharCount><pdfWordCount>6539</pdfWordCount><pdfCharCount>44857</pdfCharCount><pdfPageCount>12</pdfPageCount><abstractWordCount>271</abstractWordCount></qualityIndicators><title>Asymmetrical olfactory acuity and neuroleptic treatment in schizophrenia</title><pii><json:string>S0920-9964(99)00212-1</json:string></pii><genre><json:string>research-article</json:string></genre><host><volume>44</volume><pii><json:string>S0920-9964(00)X0063-1</json:string></pii><pages><last>232</last><first>221</first></pages><issn><json:string>0920-9964</json:string></issn><issue>3</issue><genre><json:string>Journal</json:string></genre><language><json:string>unknown</json:string></language><title>Schizophrenia Research</title><publicationDate>2000</publicationDate></host><categories><wos><json:string>PSYCHIATRY</json:string></wos></categories><publicationDate>1999</publicationDate><copyrightDate>2000</copyrightDate><doi><json:string>10.1016/S0920-9964(99)00212-1</json:string></doi><id>BB6AABFDC91AA33BC678D96652290E9E4C584961</id><score>1</score><fulltext><json:item><original>true</original><mimetype>application/pdf</mimetype><extension>pdf</extension><uri>https://api.istex.fr/document/BB6AABFDC91AA33BC678D96652290E9E4C584961/fulltext/pdf</uri></json:item><json:item><original>true</original><mimetype>text/plain</mimetype><extension>txt</extension><uri>https://api.istex.fr/document/BB6AABFDC91AA33BC678D96652290E9E4C584961/fulltext/txt</uri></json:item><json:item><original>false</original><mimetype>application/zip</mimetype><extension>zip</extension><uri>https://api.istex.fr/document/BB6AABFDC91AA33BC678D96652290E9E4C584961/fulltext/zip</uri></json:item><istex:fulltextTEI uri="https://api.istex.fr/document/BB6AABFDC91AA33BC678D96652290E9E4C584961/fulltext/tei"><teiHeader><fileDesc><titleStmt><title level="a">Asymmetrical olfactory acuity and neuroleptic treatment in schizophrenia</title></titleStmt><publicationStmt><authority>ISTEX</authority><publisher>ELSEVIER</publisher><availability><p>ELSEVIER</p></availability><date>2000</date></publicationStmt><notesStmt><note>A preliminary report from this study was presented at the 10th Biennial Meeting of the International Congress on Schizophrenia Research, Davos, Switzerland, 1998.</note><note type="content">Table 1: Olfactory acuity and identification in unmedicated patients with schizophrenia and normal controls</note><note type="content">Table 2: Olfactory identification and acuity before and after neuroleptic treatment (n=10)</note></notesStmt><sourceDesc><biblStruct type="inbook"><analytic><title level="a">Asymmetrical olfactory acuity and neuroleptic treatment in schizophrenia</title><author><persName><forename type="first">S.E.</forename><surname>Purdon</surname></persName><affiliation>Alberta Hospital Edmonton, Box 307, Edmonton, Alberta, T5J 2J7 Canada</affiliation></author><author><persName><forename type="first">P.</forename><surname>Flor-Henry</surname></persName><email>scot.Purdon@AMHB.AB.CA</email><note type="correspondence"><p>Corresponding author. Tel: +1-403-472-5525; fax: +1-403-472-5398</p></note><affiliation>Alberta Hospital Edmonton, Box 307, Edmonton, Alberta, T5J 2J7 Canada</affiliation></author></analytic><monogr><title level="j">Schizophrenia Research</title><title level="j" type="abbrev">SCHRES</title><idno type="pISSN">0920-9964</idno><idno type="PII">S0920-9964(00)X0063-1</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="1999"></date><biblScope unit="volume">44</biblScope><biblScope unit="issue">3</biblScope><biblScope unit="page" from="221">221</biblScope><biblScope unit="page" to="232">232</biblScope></imprint></monogr><idno type="istex">BB6AABFDC91AA33BC678D96652290E9E4C584961</idno><idno type="DOI">10.1016/S0920-9964(99)00212-1</idno><idno type="PII">S0920-9964(99)00212-1</idno></biblStruct></sourceDesc></fileDesc><profileDesc><creation><date>2000</date></creation><langUsage><language ident="en">en</language></langUsage><abstract xml:lang="en"><p>Uni-rhinal olfactory acuity in schizophrenia was investigated in two experiments. The first assessed the presence of a predicted atypical asymmetry of nostril laterality and the second assessed the effect of antipsychotic treatment on the asymmetry. Although olfactory identification impairment has been well documented in schizophrenia, olfactory acuity has been neglected. This may be an oversight as cerebral structures of the mesial temporal lobe important to olfactory perception have often been implicated in the pathophysiology of schizophrenia and it is thus reasonable to postulate a primary impairment of olfactory acuity in schizophrenia. In addition, unmedicated patients with schizophrenia have exhibited asymmetrical laterality favouring the right over the left hemisphere in studies of visual, haptic, and auditory perception, and the few published prospective treatment studies have suggested a reversal of this asymmetry with first generation neuroleptic treatments. In experiment 1 a generalization of the perceptual asymmetry to olfactory acuity was examined by measurement of n-butanol olfactory thresholds with the Connecticut Chemosensory Perception Exam (CCPE) in an unmedicated sample of 17 patients with schizophrenia and 17 age, gender, and handedness matched normal controls. The patient sample showed an asymmetrical impairment of the left nostril that was not apparent in the normal control sample. In experiment 2, the CCPE was administered to a new sample of 10 patients with schizophrenia before and after neuroleptic treatment. The asymmetry observed in experiment 1 was replicated, and the relative advantage of the right nostril shifted to a relative advantage of the left nostril over the course of 8weeks of treatment. Results are discussed in relation to cerebral aspects of schizophrenia and potential implications to cognitive change from treatment.</p></abstract><textClass xml:lang="en"><keywords scheme="keyword"><list><head>Keywords</head><item><term>acuity</term></item><item><term>asymmetry</term></item><item><term>laterality</term></item><item><term>neuroleptic.</term></item><item><term>olfaction</term></item><item><term>schizophrenia</term></item><item><term>UPSIT</term></item></list></keywords></textClass></profileDesc><revisionDesc><change when="1999-06-25">Registration</change><change when="1999-06-18">Modified</change><change when="1999">Published</change></revisionDesc></teiHeader></istex:fulltextTEI></fulltext><metadata><istex:metadataXml wicri:clean="Elsevier, elements deleted: ce:floats; body; tail"><istex:xmlDeclaration>version="1.0" encoding="utf-8"</istex:xmlDeclaration><istex:docType PUBLIC="-//ES//DTD journal article DTD version 4.5.2//EN//XML" URI="art452.dtd" name="istex:docType"></istex:docType><istex:document><converted-article version="4.5.2" docsubtype="fla"><item-info><jid>SCHRES</jid><aid>1247</aid><ce:pii>S0920-9964(99)00212-1</ce:pii><ce:doi>10.1016/S0920-9964(99)00212-1</ce:doi><ce:copyright type="full-transfer" year="2000">Elsevier Science B.V.</ce:copyright></item-info><head><ce:article-footnote><ce:label>☆</ce:label><ce:note-para>A preliminary report from this study was presented at the 10th Biennial Meeting of the International Congress on Schizophrenia Research, Davos, Switzerland, 1998.</ce:note-para></ce:article-footnote><ce:title>Asymmetrical olfactory acuity and neuroleptic treatment in schizophrenia</ce:title><ce:author-group><ce:author><ce:given-name>S.E.</ce:given-name><ce:surname>Purdon</ce:surname></ce:author><ce:author><ce:given-name>P.</ce:given-name><ce:surname>Flor-Henry</ce:surname><ce:cross-ref refid="CORR1">*</ce:cross-ref><ce:e-address>scot.Purdon@AMHB.AB.CA</ce:e-address></ce:author><ce:affiliation><ce:textfn>Alberta Hospital Edmonton, Box 307, Edmonton, Alberta, T5J 2J7 Canada</ce:textfn></ce:affiliation><ce:correspondence id="CORR1"><ce:label>*</ce:label><ce:text>Corresponding author. Tel: +1-403-472-5525; fax: +1-403-472-5398</ce:text></ce:correspondence></ce:author-group><ce:date-received day="2" month="2" year="1999"></ce:date-received><ce:date-revised day="18" month="6" year="1999"></ce:date-revised><ce:date-accepted day="25" month="6" year="1999"></ce:date-accepted><ce:abstract><ce:section-title>Abstract</ce:section-title><ce:abstract-sec><ce:simple-para>Uni-rhinal olfactory acuity in schizophrenia was investigated in two experiments. The first assessed the presence of a predicted atypical asymmetry of nostril laterality and the second assessed the effect of antipsychotic treatment on the asymmetry. Although olfactory identification impairment has been well documented in schizophrenia, olfactory acuity has been neglected. This may be an oversight as cerebral structures of the mesial temporal lobe important to olfactory perception have often been implicated in the pathophysiology of schizophrenia and it is thus reasonable to postulate a primary impairment of olfactory acuity in schizophrenia. In addition, unmedicated patients with schizophrenia have exhibited asymmetrical laterality favouring the right over the left hemisphere in studies of visual, haptic, and auditory perception, and the few published prospective treatment studies have suggested a reversal of this asymmetry with first generation neuroleptic treatments. In experiment 1 a generalization of the perceptual asymmetry to olfactory acuity was examined by measurement of n-butanol olfactory thresholds with the Connecticut Chemosensory Perception Exam (CCPE) in an unmedicated sample of 17 patients with schizophrenia and 17 age, gender, and handedness matched normal controls. The patient sample showed an asymmetrical impairment of the left nostril that was not apparent in the normal control sample. In experiment 2, the CCPE was administered to a new sample of 10 patients with schizophrenia before and after neuroleptic treatment. The asymmetry observed in experiment 1 was replicated, and the relative advantage of the right nostril shifted to a relative advantage of the left nostril over the course of 8<ce:hsp sp="0.25"></ce:hsp>weeks of treatment. Results are discussed in relation to cerebral aspects of schizophrenia and potential implications to cognitive change from treatment.</ce:simple-para></ce:abstract-sec></ce:abstract><ce:keywords xml:lang="en"><ce:section-title>Keywords</ce:section-title><ce:keyword><ce:text>acuity</ce:text></ce:keyword><ce:keyword><ce:text>asymmetry</ce:text></ce:keyword><ce:keyword><ce:text>laterality</ce:text></ce:keyword><ce:keyword><ce:text>neuroleptic.</ce:text></ce:keyword><ce:keyword><ce:text>olfaction</ce:text></ce:keyword><ce:keyword><ce:text>schizophrenia</ce:text></ce:keyword><ce:keyword><ce:text>UPSIT</ce:text></ce:keyword></ce:keywords></head></converted-article></istex:document></istex:metadataXml><mods version="3.6"><titleInfo><title>Asymmetrical olfactory acuity and neuroleptic treatment in schizophrenia</title></titleInfo><titleInfo type="alternative" contentType="CDATA"><title>Asymmetrical olfactory acuity and neuroleptic treatment in schizophrenia</title></titleInfo><name type="personal"><namePart type="given">S.E.</namePart><namePart type="family">Purdon</namePart><affiliation>Alberta Hospital Edmonton, Box 307, Edmonton, Alberta, T5J 2J7 Canada</affiliation><role><roleTerm type="text">author</roleTerm></role></name><name type="personal"><namePart type="given">P.</namePart><namePart type="family">Flor-Henry</namePart><affiliation>Alberta Hospital Edmonton, Box 307, Edmonton, Alberta, T5J 2J7 Canada</affiliation><affiliation>E-mail: scot.Purdon@AMHB.AB.CA</affiliation><description>Corresponding author. Tel: +1-403-472-5525; fax: +1-403-472-5398</description><role><roleTerm type="text">author</roleTerm></role></name><typeOfResource>text</typeOfResource><genre type="research-article" displayLabel="Full-length article"></genre><originInfo><publisher>ELSEVIER</publisher><dateIssued encoding="w3cdtf">1999</dateIssued><dateValid encoding="w3cdtf">1999-06-25</dateValid><dateModified encoding="w3cdtf">1999-06-18</dateModified><copyrightDate encoding="w3cdtf">2000</copyrightDate></originInfo><language><languageTerm type="code" authority="iso639-2b">eng</languageTerm><languageTerm type="code" authority="rfc3066">en</languageTerm></language><physicalDescription><internetMediaType>text/html</internetMediaType></physicalDescription><abstract lang="en">Uni-rhinal olfactory acuity in schizophrenia was investigated in two experiments. The first assessed the presence of a predicted atypical asymmetry of nostril laterality and the second assessed the effect of antipsychotic treatment on the asymmetry. Although olfactory identification impairment has been well documented in schizophrenia, olfactory acuity has been neglected. This may be an oversight as cerebral structures of the mesial temporal lobe important to olfactory perception have often been implicated in the pathophysiology of schizophrenia and it is thus reasonable to postulate a primary impairment of olfactory acuity in schizophrenia. In addition, unmedicated patients with schizophrenia have exhibited asymmetrical laterality favouring the right over the left hemisphere in studies of visual, haptic, and auditory perception, and the few published prospective treatment studies have suggested a reversal of this asymmetry with first generation neuroleptic treatments. In experiment 1 a generalization of the perceptual asymmetry to olfactory acuity was examined by measurement of n-butanol olfactory thresholds with the Connecticut Chemosensory Perception Exam (CCPE) in an unmedicated sample of 17 patients with schizophrenia and 17 age, gender, and handedness matched normal controls. The patient sample showed an asymmetrical impairment of the left nostril that was not apparent in the normal control sample. In experiment 2, the CCPE was administered to a new sample of 10 patients with schizophrenia before and after neuroleptic treatment. The asymmetry observed in experiment 1 was replicated, and the relative advantage of the right nostril shifted to a relative advantage of the left nostril over the course of 8weeks of treatment. Results are discussed in relation to cerebral aspects of schizophrenia and potential implications to cognitive change from treatment.</abstract><note>A preliminary report from this study was presented at the 10th Biennial Meeting of the International Congress on Schizophrenia Research, Davos, Switzerland, 1998.</note><note type="content">Table 1: Olfactory acuity and identification in unmedicated patients with schizophrenia and normal controls</note><note type="content">Table 2: Olfactory identification and acuity before and after neuroleptic treatment (n=10)</note><subject lang="en"><genre>Keywords</genre><topic>acuity</topic><topic>asymmetry</topic><topic>laterality</topic><topic>neuroleptic.</topic><topic>olfaction</topic><topic>schizophrenia</topic><topic>UPSIT</topic></subject><relatedItem type="host"><titleInfo><title>Schizophrenia Research</title></titleInfo><titleInfo type="abbreviated"><title>SCHRES</title></titleInfo><genre type="Journal">journal</genre><originInfo><dateIssued encoding="w3cdtf">20000901</dateIssued></originInfo><identifier type="ISSN">0920-9964</identifier><identifier type="PII">S0920-9964(00)X0063-1</identifier><part><date>20000901</date><detail type="volume"><number>44</number><caption>vol.</caption></detail><detail type="issue"><number>3</number><caption>no.</caption></detail><extent unit="issue pages"><start>165</start><end>254</end></extent><extent unit="pages"><start>221</start><end>232</end></extent></part></relatedItem><identifier type="istex">BB6AABFDC91AA33BC678D96652290E9E4C584961</identifier><identifier type="DOI">10.1016/S0920-9964(99)00212-1</identifier><identifier type="PII">S0920-9964(99)00212-1</identifier><accessCondition type="use and reproduction" contentType="">© 2000Elsevier Science B.V.</accessCondition><recordInfo><recordContentSource>ELSEVIER</recordContentSource><recordOrigin>Elsevier Science B.V., ©2000</recordOrigin></recordInfo></mods></metadata><enrichments><istex:catWosTEI uri="https://api.istex.fr/document/BB6AABFDC91AA33BC678D96652290E9E4C584961/enrichments/catWos"><teiHeader><profileDesc><textClass><classCode scheme="WOS">PSYCHIATRY</classCode></textClass></profileDesc></teiHeader></istex:catWosTEI></enrichments><serie></serie></istex></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Ticri/CIDE/explor/HapticV1/Data/Istex/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004596 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Istex/Corpus/biblio.hfd -nk 004596 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Ticri/CIDE
|area= HapticV1
|flux= Istex
|étape= Corpus
|type= RBID
|clé= ISTEX:BB6AABFDC91AA33BC678D96652290E9E4C584961
|texte= Asymmetrical olfactory acuity and neuroleptic treatment in schizophrenia
}}
| This area was generated with Dilib version V0.6.23. |  |